Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 3051
TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 303544BDBM303544(US10138229, Example 55 | US9951056, Example 12 | U...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389637BDBM389637(US9951056, Example 11 | 1-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389636BDBM389636(US9951056, Example 10 | 6-(3-acrylamidopyrrolidin-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389635BDBM389635(US9951056, Example 8 | 6-(1-acryloylpiperidin-3-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389644BDBM389644(US9951056, Example 17 | 1-(3-aminophenyl)-3-(4-phe...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389643BDBM389643(US9951056, Example 16 | 1-(4-acrylamidophenyl)-3-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389642BDBM389642(US9951056, Example 15 | 1-(1-acryloylazetidin-3-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389641BDBM389641(US9951056, Example 13 | 1-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389630BDBM389630(US9951056, Example 1 | 6-(3-acrylamidophenyl)-2-(4...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389634BDBM389634(US9951056, Example 7 | 6-(4-acrylamidophenyl)-2-(4...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389633BDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389632BDBM389632(US9951056, Example 5 | 6-(4-acryloylpiperazin-1-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389631BDBM389631(US9951056, Example 3 | 6-(1-acryloylpiperidin-4-yl...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389656BDBM389656(US9951056, Example 34 | 1-(1-(4-(dimethylamino)but...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389655BDBM389655(US9951056, Example 32 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389654BDBM389654(US9951056, Example 29 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389653BDBM389653(US9951056, Example 28 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389660BDBM389660(US9951056, Example 38 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389659BDBM389659(US9951056, Example 37 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389658BDBM389658(US9951056, Example 36 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389657BDBM389657(US9951056, Example 35 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389648BDBM389648(US9951056, Example 21 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389647BDBM389647(US9951056, Example 20 | (R)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389646BDBM389646(US9951056, Example 19 | (S)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389645BDBM389645(US9951056, Example 18 | 1-(3-acrylamidophenyl)-3-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389652BDBM389652(US9951056, Example 26 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389651BDBM389651(US9951056, Example 25 | (E)-6-(4-(4-(dimethylamino...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389633BDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389649BDBM389649(US9951056, Example 22 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389672BDBM389672(US9951056, Example 51 | 2-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389671BDBM389671(US9951056, Example 49 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389670BDBM389670(US9951056, Example 48 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389669BDBM389669(US9951056, Example 47 | 2-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389676BDBM389676(US9951056, Example 57 | 5-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389675BDBM389675(US9951056, Example 55 | 5-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389674BDBM389674(US9951056, Example 54 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389673BDBM389673(US9951056, Example 52 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389664BDBM389664(US9951056, Example 42 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389663BDBM389663(US9951056, Example 41 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389662BDBM389662(US9951056, Example 40 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389661BDBM389661(US9951056, Example 39 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389668BDBM389668(US9951056, Example 46 | 2-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389667BDBM389667(US9951056, Example 45 | 2-(1-acryloylpiperidin-3-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389666BDBM389666(US9951056, Example 44 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389665BDBM389665(US9951056, Example 43 | 2-(1-acryloylpyrrolidin-3-...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389681BDBM389681(US9951056, Example 61 | 6-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389680BDBM389680(US9951056, Example 60 | 6-(4-acryloylpiperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389679BDBM389679(US9951056, Example 59 | (E)-1-(1-(2-cyanobut-2-eno...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 389678BDBM389678(US9951056, Example 58 | 6-(1-acryloylpiperidin-4-y...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Beijing Innocare Pharma Tech

US Patent
LigandChemical structure of BindingDB Monomer ID 390425BDBM390425(US9951056, Example 63 | 2-(4-phenoxyphenyl)-6-(1-(...)
Affinity DataIC50: 500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2020
Entry Details
US Patent

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: